2022
DOI: 10.3389/fnsys.2022.1044686
|View full text |Cite
|
Sign up to set email alerts
|

The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia

Abstract: Due to the prevalence of chronic pain worldwide, there is an urgent need to improve pain management strategies. While opioid drugs have long been used to treat chronic pain, their use is severely limited by adverse effects and abuse liability. Neurostimulation techniques have emerged as a promising option for chronic pain that is refractory to other treatments. While different neurostimulation strategies have been applied to many neural structures implicated in pain processing, there is variability in efficacy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 364 publications
(438 reference statements)
0
6
0
Order By: Relevance
“…One plausible mechanism of action for DRG-S involves stimulation of low-threshold mechanoreceptors that in turn trigger spinal endogenous opioid receptor activation. 13 Analgesia through opioid receptor activation is known to be particularly effective for all types of chronic pain, including nociceptive pain. 14 It has also been postulated that neuromodulation with bioelectronic medicine therapies such as DRG-S that target the autonomic nervous system may be able to treat osteoarthritis-related pain and pathogenesis by reducing related neurogenic inflammation and preventing maladaptive nervous system plasticity.…”
Section: Discussionmentioning
confidence: 99%
“…One plausible mechanism of action for DRG-S involves stimulation of low-threshold mechanoreceptors that in turn trigger spinal endogenous opioid receptor activation. 13 Analgesia through opioid receptor activation is known to be particularly effective for all types of chronic pain, including nociceptive pain. 14 It has also been postulated that neuromodulation with bioelectronic medicine therapies such as DRG-S that target the autonomic nervous system may be able to treat osteoarthritis-related pain and pathogenesis by reducing related neurogenic inflammation and preventing maladaptive nervous system plasticity.…”
Section: Discussionmentioning
confidence: 99%
“…However, despite these reports, which have not been fully confirmed, the exact mechanism remains to be determined. Nevertheless, the potential for disorienting psychoactive, respiratory depression, and other side effects in chronic pain patients who manage only with opioid drugs may be the impetus for an in-depth discovery of the mechanisms at play here and thus originate novel effective and tolerable treatment paradigms to lessen the suffering of patients [ 50 ].…”
Section: Brain Stimulation Methods For Chronic Painmentioning
confidence: 99%
“…Pain perception is regulated via the ascending nociceptive pathway and the descending modulatory system, both of which represent the main conduits for nociceptive signaling (Table ). The reaction to noxious stimuli is a multifaceted process mediated by diverse cerebral structures. These structures comprise the anterior cingulate cortex, insular cortex, thalamus, and periaqueductal gray matter …”
Section: Central Nervous System Alterations In Aging-related Neuropat...mentioning
confidence: 99%